This brand name is authorized in Austria, Australia, Cyprus, Estonia, Spain, Finland, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, United States
The drug SEGLUROMET contains a combination of these active pharmaceutical ingredients (APIs):
1
Ertugliflozin
UNII MLU731K321 - ERTUGLIFLOZIN PIDOLATE
|
Ertugliflozin helps to lower blood glucose by making the patient pass out glucose in the urine. It does this by blocking a protein in the kidneys (called SGLT2) that normally takes glucose back into the blood from the kidneys. |
2
Metformin
UNII 786Z46389E - METFORMIN HYDROCHLORIDE
|
Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
SEGLUROMET Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A10BD23 | Metformin and ertugliflozin | A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 11562M, 11563N, 11564P, 11568W, 11569X, 11575F, 11581M, 11584Q |
Country: EE | Ravimiamet | Identifier(s): 1767630, 1767641, 1767652, 1767663, 1767674, 1767685, 1767696, 1767708, 1767719, 1767720, 1767731, 1767742, 1767753, 1767764, 1767775, 1767786, 1767797, 1767809, 1767810, 1767821, 1767832, 1767843, 1767854, 1767865, 1767876, 1767887, 1767898, 1767900, 1777709, 1777710, 1777721, 1777732 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1181265011, 1181265025 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 088817, 459845, 489128, 511418 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8309, 8310 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1085295, 1085296, 1085297, 1085298, 1085299, 1085300, 1085301, 1085302, 1085303, 1085304, 1085305, 1085306, 1085307, 1085308, 1085309, 1085310, 1085311, 1085312, 1085313, 1085314, 1085315, 1085316, 1085317, 1085318, 1085319, 1085320, 1085321, 1085322, 1086580, 1086581, 1086582, 1086583 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 167711, 167738 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100403947, 100404668, 100404674, 100404680 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66529001, W66529002, W66529003, W66529004, W66530001, W66530002, W66530003, W66530004 |
Country: US | FDA, National Drug Code | Identifier(s): 0006-5369, 0006-5370, 0006-5373, 0006-5374 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.